We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Moderna’s COVID-19 Vaccine Shown to Be Effective in Adolescents
Moderna’s COVID-19 Vaccine Shown to Be Effective in Adolescents
Moderna said its COVID-19 vaccine offered strong protection against infection in adolescents ages 12 to 17 years in a phase 2/3 study, paving the way for the company to seek a revised Emergency Use Authorization that covers this population.